fig3
Figure 3. Structures of inhibitors of PI3K-AKT-mTOR signaling (kinase targets in brackets) with effects on MYB activity and/or MYB-dependent cancers (green: mechanisms; red: targeted cancers). PI3K: Phosphoinositide 3 kinase; AKT: protein kinase B; mTOR: mammalian target of rapamycin.
